KEMPHARM, INC - FORM S-1 - EX-23.1 - March 11, 2015

Attached files

file filename
S-1 - FORM S-1 - KEMPHARM, INCd793437ds1.htm
EX-3.1 - EX-3.1 - KEMPHARM, INCd793437dex31.htm
EX-3.3 - EX-3.3 - KEMPHARM, INCd793437dex33.htm
EX-3.4 - EX-3.4 - KEMPHARM, INCd793437dex34.htm
EX-10.1 - EX-10.1 - KEMPHARM, INCd793437dex101.htm
EX-10.3 - EX-10.3 - KEMPHARM, INCd793437dex103.htm
EX-3.5 - EX-3.5 - KEMPHARM, INCd793437dex35.htm
EX-2.1 - EX-2.1 - KEMPHARM, INCd793437dex21.htm
EX-10.6 - EX-10.6 - KEMPHARM, INCd793437dex106.htm
EX-10.2 - EX-10.2 - KEMPHARM, INCd793437dex102.htm
EX-10.9 - EX-10.9 - KEMPHARM, INCd793437dex109.htm
EX-10.7 - EX-10.7 - KEMPHARM, INCd793437dex107.htm
EX-10.5 - EX-10.5 - KEMPHARM, INCd793437dex105.htm
EX-10.4 - EX-10.4 - KEMPHARM, INCd793437dex104.htm
EX-10.24 - EX-10.24 - KEMPHARM, INCd793437dex1024.htm
EX-10.16 - EX-10.16 - KEMPHARM, INCd793437dex1016.htm
EX-10.2.1 - EX-10.2.1 - KEMPHARM, INCd793437dex1021.htm
EX-10.8.1 - EX-10.8.1 - KEMPHARM, INCd793437dex1081.htm
EX-10.10 - EX-10.10 - KEMPHARM, INCd793437dex1010.htm
EX-10.20 - EX-10.20 - KEMPHARM, INCd793437dex1020.htm
EX-10.13 - EX-10.13 - KEMPHARM, INCd793437dex1013.htm
EX-10.23 - EX-10.23 - KEMPHARM, INCd793437dex1023.htm
EX-10.15 - EX-10.15 - KEMPHARM, INCd793437dex1015.htm
EX-10.11 - EX-10.11 - KEMPHARM, INCd793437dex1011.htm
EX-10.18 - EX-10.18 - KEMPHARM, INCd793437dex1018.htm
EX-10.8.2 - EX-10.8.2 - KEMPHARM, INCd793437dex1082.htm
EX-10.17 - EX-10.17 - KEMPHARM, INCd793437dex1017.htm
EX-10.22 - EX-10.22 - KEMPHARM, INCd793437dex1022.htm
EX-10.12 - EX-10.12 - KEMPHARM, INCd793437dex1012.htm
EX-10.14 - EX-10.14 - KEMPHARM, INCd793437dex1014.htm
EX-10.19 - EX-10.19 - KEMPHARM, INCd793437dex1019.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 11, 2015, in the Registration Statement (Form S-1) and related Prospectus of KemPharm, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Minneapolis, Minnesota

March 11, 2015

KEMPHARM, INC Reports